Back to top

Tale of the Tape

Zacks Equity Research

Oncothyreon Inc. (ONTY) in Focus: Stock up 9.3%
February 26, 2014


Trades from $3

Oncothyreon Inc. was a big mover last session, as the company saw its shares jump a little over 9% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 53% in the past one-month time frame.

Over the last 30 days, Oncothyreon did not witness any estimate revision and the Zacks Consensus Estimate has remained unchanged. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Oncothyreon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN - Analyst Report) , Biogen Idec Inc. (BIIB - Analyst Report) with a Zacks Rank #1 (Strong Buy) and Cambrex Corporation.(CBM - Snapshot Report) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>